Antiviral activity of bovine type III interferon against foot-and-mouth disease virus (Q39571120)

13 September 2017

Antiviral activity of bovine type III interferon against foot-and-mouth disease virus (English)

1 reference

foot-and-mouth disease virus

13 September 2017

foot-and-mouth disease

1 reference

based on heuristic

inferred from title

object named as

foot-and-mouth disease virus

1 reference

6

Marvin J Grubman

1 reference

13 September 2017

Fayna Diaz-San Segundo

1

object named as

Fayna Díaz-San Segundo

1 reference

13 September 2017

Marcelo Weiss

2

1 reference

13 September 2017

Eva Perez-Martín

3

1 reference

13 September 2017

Marla J Koster

4

1 reference

13 September 2017

James Zhu

5

1 reference

13 September 2017

Teresa de los Santos

7

1 reference

13 September 2017

language of work or name

English

0 references

publication date

24 March 2011

1 reference

13 September 2017

1 reference

13 September 2017

413

1 reference

13 September 2017

2

1 reference

13 September 2017

283-292

1 reference

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

The early pathogenesis of foot-and-mouth disease in cattle after aerosol inoculation. Identification of the nasopharynx as the primary site of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Viruses and the type I interferon antiviral system: induction and evasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Improved prediction of signal peptides: SignalP 3.0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Interferons and viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

7 January 2021

Foot-and-mouth disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

IRF-7 is the master regulator of type-I interferon-dependent immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Expression of Mx protein and interferon-alpha in pigs experimentally infected with swine influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Molecular cloning, expression, and characterization of chicken IFN -lambda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Biological activity of interleukins-28 and -29: comparison with type I interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

pAd5-Blue: direct ligation system for engineering recombinant adenovirus constructs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

What have we learned from the IL28 receptor knockout mouse?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Early events in the pathogenesis of foot-and-mouth disease in cattle after controlled aerosol exposure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Lambda interferon inhibits hepatitis B and C virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Molecular characterization and antiviral analyses of porcine type III interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Differential expression and activity of the porcine type I interferon family.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Control of foot and mouth disease: lessons from the experience of the outbreak in Great Britain in 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

IL-28, IL-29 and their class II cytokine receptor IL-28R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

How cells respond to interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Characterization of the murine alpha interferon gene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Differential gene expression in bovine cells infected with wild type and leaderless foot-and-mouth disease virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.02.023

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2011.02.023

1 reference

13 September 2017

1 reference